financetom
Business
financetom
/
Business
/
Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients
Jan 14, 2025 6:15 AM

08:59 AM EST, 01/14/2025 (MT Newswires) -- Adaptive Biotechnologies ( ADPT ) and NeoGenomics ( NEO ) said Tuesday they are partnering to support access to minimal residual disease monitoring options for patients with certain blood cancers.

The multiyear deal is meant to support bespoke treatment strategies and immediate insights into disease progression, the companies said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
 Canadian cloud-based SaaS provider Descartes Systems Q2 revenue beats estimates
 Canadian cloud-based SaaS provider Descartes Systems Q2 revenue beats estimates
Sep 3, 2025
Overview * Descartes Systems Group ( DSGX ) fiscal Q2 rev grows 10% yr/yr, beating analyst expectations, per LSEG data * Adjusted EBITDA for fiscal Q2 beats estimates, per LSEG data Outlook * Company notes challenging market conditions impacting customer pricing decisions * Descartes highlights reliance on its Global Logistics Network amid trade uncertainties Result Drivers * GLOBAL LOGISTICS NETWORK...
Novo Resources Provides Updates for H2; Drilling Commenced at Sherlock Crossing
Novo Resources Provides Updates for H2; Drilling Commenced at Sherlock Crossing
Sep 3, 2025
05:10 PM EDT, 09/03/2025 (MT Newswires) -- Novo Resources ( NSRPF ) after trade Wednesday provided an update on its exploration activities on its Australian mineral projects for the second half of 2025. In the Pilbara region, Novo started its first reverse circulation (RC) drill program at Sherlock Crossing, targeting high-grade gold and antimony mineralization at the Clarke Mine, the...
Gitlab Fiscal Q2 Non-GAAP Net Income, Revenue Rise; FY EPS Guidance Raised; Shares Fall After Hours
Gitlab Fiscal Q2 Non-GAAP Net Income, Revenue Rise; FY EPS Guidance Raised; Shares Fall After Hours
Sep 3, 2025
05:08 PM EDT, 09/03/2025 (MT Newswires) -- GitLab ( GTLB ) reported fiscal Q2 non-GAAP net income late Wednesday of $0.24 per diluted share, up from $0.15 a year earlier. Analysts surveyed by FactSet expected $0.16. Revenue in the three months ended July 31 rose to $235.9 million from $182.6 million a year earlier. Analysts polled by FactSet expected $226.9...
Advanced Flower Capital Insider Bought Shares Worth $330,526, According to a Recent SEC Filing
Advanced Flower Capital Insider Bought Shares Worth $330,526, According to a Recent SEC Filing
Sep 3, 2025
05:09 PM EDT, 09/03/2025 (MT Newswires) -- Leonard M Tannenbaum, 10% Owner, Director, on September 02, 2025, executed a purchase for 72,957 shares in Advanced Flower Capital ( AFCG ) for $330,526. Following the Form 4 filing with the SEC, Tannenbaum has control over a total of 5,190,573 common shares of the company, with 4,882,506 shares held directly and 308,067...
Copyright 2023-2026 - www.financetom.com All Rights Reserved